Matthew C Biggerstaff, D.O. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 9468 Ne 27th St, Ankeny, IA 50021 Phone: 515-313-8649 |
News Archive
Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.
4SC AG, the German drug discovery and development company, today announced the dosing of the first patient in its Phase II trial with 4SC-201 (resminostat), a pan-histone deacetylase (HDAC) inhibitor, as a new potential treatment option for patients with advanced hepatocellular carcinoma (HCC), the most frequent form of liver cancer.
The Washington Post takes a look at the report by a group representing mental health professionals, and also how the issue is playing out in the Virginia legislature, where there is strong support to reform the state's mental health care system following the death of a state lawmaker's son.
Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body - with an eye to developing a safer alternative.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
› Verified 4 days ago